Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Industry: Healthcare

Clinerion partners with PPC to bring Patient Network Explorer coverage and services to patients and hospitals in Korea, China and Taiwan

Leave a comment



BASEL, Switzerland (PRWEB)

As part of the partnership, PPC will use the Patient Network Explorer platform to advance clinical trials, trial enrollment, and accelerate global studies conducted in the People’s Republic of China, the Republic of China (Taiwan) and the Republic of Korea (South Korea). PPC will encourage hospitals to participate in Clinerion’s Patient Network Explorer platform for generation of RWD/RWE and bringing more global studies to hospitals.

PPC provides a fully integrated solution for Phase I-IV studies in Asian countries. PPC is dedicated to serve the pharmaceutical and biotechnology industry with world-class quality and cost-effective solutions to shorten the lead time to market. PPC provides full services for clinical trials, such as Project Management, Regulatory Affairs, Clinical Monitoring, Biostatistics, Data Management, Medical Writing, and Pharmacovigilance.

Patient Network Explorer supports patient health by matching patients from Clinerion’s global network of hospitals to clinical trials conducted by pharmaceutical sponsors or researchers performing academic investigations. The system is based on de-identified EHR data, unlinked from any identifiers, protecting patient privacy. The partners’ combined services will accelerate access for patients and hospitals to next-generation medical treatments. Patients in the region will become more visible to sponsors for trial recruitment, and hospitals in the region will become better placed to run clinical trials, ultimately accelerating drug launch.

“We are excited to be partnering with Clinerion to jointly offer our customers access to global integrated recruitment services through the Patient Network Explorer platform,” says Michael Stibilj, CEO of PPC. “This relationship will enable researchers and hospitals, in our region, to have additional opportunities to be involved in global trials, also providing patients access to new potential treatments. Increased access to patients will speed up the clinical trial process and help accelerate the development of break-through products.”

“The strength of Patient Network Explorer lies in its global coverage,” says Ian Rentsch, Clinerion CEO. “Clinerion’s hospital network currently covers 19 countries and over 73 M patients. The partnership with PPC promises to deepen our presence in Korea and Taiwan, and expand our coverage to China. Clinerion continues to build our global presence!”

About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

Clinerion website: http://www.clinerion.com

Clinerion’s Patient Network Explorer: http://www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer

For more information, please contact:

Le Vin Chin

Director, Head of Marketing & Communications

Clinerion Ltd

Elisabethenanlage 11, 4051 Basel, Switzerland

Tel.: +41 61 865 60 54

media@clinerion.com

About PPC.

PPC group was founded in 1997, provides professional services for clinical studies to pharmaceutical and biotechnology companies. PPC offers clinical and laboratory services in China, Taiwan, Korea and Japan. Since 1997, PPC has completed over 2000 early phase trials including innovative phase I pharmacokinetic, generic bioequivalence and biosimilar studies for local and global pharmaceuticals companies in Asia. In addition, PPC has conducted over 500 innovative phase II- IV trials, covering 24 therapeutic areas. PPC group has 7 offices, 4 phase I units, 3 bioanalytical labs and 1 central lab in China, Taiwan, Korea and Japan, employing over 600 staff.

PPC website: http://www.ppccro.com

For more information, please contact:

Gerard Kim

Business Development Associate

PPC Korea Co., Ltd.

20F, SamWon Tower 124, Teheran-ro, Gangnam-gu, Seoul, Korea, 06234

Tel.: +82 2 2054 0651

Fax: +82 2 535 0511

Mobile: +82 10 5264 4105

junghoon.kim@ppccro.com

Share article on social media or email:

Health

Allied Environmental Services adds Electrofusion Pipe Welding to Expanding List of Services

Leave a comment


https://www.prweb.com/

Electrofusion repairs at landfill facility

We primarily work at environmentally sensitive facilities where exceptional quality work is a must


BUFFALO, N.Y. (PRWEB)

In response to client input and the needs of industry in the western New York region, Allied began building the electrofusion welding service offering in the first quarter 2019. According to Linda Grimmer, Allied Buffalo Branch Manager, Allied made considerable investment in the equipment, training and resources required to offer professional and high-quality service. “We primarily work at environmentally sensitive facilities where exceptional quality work is a must”, Grimmer stated. “Our clients were struggling to find qualified contractors to provide the electrofusion welding service, so we responded by adding the capability ourselves. When we made that commitment, we also committed to becoming expertly trained and equipped to provide outstanding quality work, which is what our clients expect and deserve,” Grimmer added.

Electrofusion welding is a method of joining medium and high-density polyethylene (MDPE & HDPE) piping through electrical resistive heat fusion. The process produces a complete and consistent weld without using solvents or adhesives, which eliminates contamination concerns at environmentally sensitive work sites, such as landfills and environmental remediation projects. It also allows for repairs to be made without removing existing piping from the ground.

According to Grimmer, electrofusion welding offers several benefits over traditional polyethylene pipe joining, especially in applications involving the installation and repair of in-situ environmental treatment systems. “The process is free of chemical solvents, which we never want to introduce to a treatment system. Also, it allows for buried pipes to be repaired in place without removing them and bringing them to the surface,” Grimmer said. “The process is less intrusive, and because the equipment is programmable, it eliminates human error and makes a more consistent weld,” she added.

Allied has more than 30 years of experience installing and repairing in-situ treatment systems. The addition of the electrofusion welding service adds an additional specialized tool to the firm’s wide range of capabilities.

About Allied Environmental Services, Inc.

Allied Environmental Services, Inc. (Allied) is an industrial maintenance and environmental field services firm headquartered in Lima, Ohio, with a branch office in Buffalo, New York. Allied provides professional on-site services to private industry, government and military facilities, railroads, municipalities, schools, and hospitals throughout the Great Lakes region. Allied specializes in emergency spill response, environmental remediation and site restoration, industrial cleaning, vacuum-truck and hydroblasting services, storage tank maintenance and removal, hazardous materials management, industrial coatings application, and asbestos and lead paint abatement.

For more information please visit Allied’s website at http://www.alliedesi.com, or contact the main office at (800) 992-5781.

Share article on social media or email:

health and fitness

Addressing the Physical and Emotional Tolls of the Pigment-Loss Condition

Leave a comment


https://www.prweb.com/

Chris Byrne, RPA-C

In most cases, vitiligo appears in corresponding patches on both sides of the body – “generalized” or “nonsegmental” vitiligo. However, cases of “segmental” vitiligo can also occur, affecting one side alone.


FRANKLIN SQUARE, N.Y. (PRWEB)

Jon Hamm attributes the blotches of white skin that appeared on his hands to a megadose of stress: He had recently taken on a big role – playing the uber-alpha drinking, smoking, philandering Don Draper in the smash hit Mad Men. In his thirties at the time, Hamm developed vitiligo. “It starts without warning,” notes Chris Byrne, a certified registered physician’s assistant specializing in dermatology with Advanced Dermatology PC. “Stress combined with an underlying autoimmune condition may trigger its onset.”

A “convergence theory,” says the nonprofit Vitiligo Research Foundation, could explain why up to two percent of us suddenly start to lose melanocytes: Some combination of stress, toxins, disease, and genes causes the death of those pigment-producing skin cells, leaving behind patches of white skin, whose appearance is especially noticeable against darker skin tones.

In most cases, vitiligo appears in corresponding patches on both sides of the body – “generalized” or “nonsegmental” vitiligo. However, cases of “segmental” vitiligo can also occur, affecting one side alone. The American Academy of Dermatology classifies those two types further: localized vitiligo affects a small area; generalized vitiligo progresses to more widespread patches; and universal vitiligo, the most rare, causes almost all skin to lose pigment.

“As with Jon Hamm,” observes Byrne, “it commonly begins on the hands. Once begun, generalized vitiligo typically starts and stops, seemingly at random. Unfortunately, research has not yet uncovered a vitiligo ‘off’ switch.”

“In most cases,” continues Byrne, “vitiligo does not cause other physical symptoms. But the emotional and psychological tolls can be severe. Early diagnosis can give patients the greatest access to treatment choices.”

In those rare cases of universal vitiligo, patients may opt to lighten the limited remaining pigmented skin. However, most patients – if they choose to treat localized or generalized cases – elect a means of adding color.

With that in mind, Byrne makes the following suggestions.

6 Answers to Help Choose a Vitiligo Treatment

1. When does makeup make sense? “Half of vitiligo cases start under the age of 21,” notes Byrne. “For children with the condition, adding color with makeup, skin dye, or self-tanners can be healthy choices, as they do not have the possible side effects of other treatments. This may also appeal to those who want a temporary, ‘as needed’ approach without side effects.”

2. What about topical corticosteroids? ”These are most effective when used early, before there is widespread pigment loss,” says Byrne. “In particular, treatment may help repigment areas of the face. Some caveats include the need to monitor for side effects, as skin atrophy can occur when used for more than a year.”

3. How can light and lasers help? “Phototherapy – UVA and UVB treatments – can help add color to more extensive areas,” explains Byrne. “For small areas, lasers can be particularly effective, with seventy percent seeing improvement. Patients should be fully informed regarding outcome, as color gain can gradually fade.”

4. What can combination therapy do? “‘PUVA’ refers to the use of psoralen – either in topical or oral form – in conjunction with UVA light treatment,” describes Byrne. “This is a long-term treatment, typically involving weekly sessions for a year. Up to seventy-five percent of the time, there is pigment gain on the face and body, including the torso and upper arms and legs. With this approach, it’s important to monitor for side effects, including vision changes. And sun protection is essential.”

5. When can surgery be considered? “Transplanting pigmented skin,” says Byrne, “can be effective but should only be considered for adults with ‘stable’ cases – that is, no pigment loss for at least six months. And surgery also carries the risk of side effects.”

6. Are new treatments on the way? “This is a hopeful time,” notes Byrne. “New topical treatments are showing promise in current research. We had exciting news this summer regarding the topical agent ruxolitinib, and the third phase of its clinical trial is now underway.”

“Vitiligo patients,” Byrne emphasizes, “need the support of caring specialists who can empower them to make informed choices.”

Bio: Christopher Byrne RPA-C is a certified physician assistant with Advanced Dermatology PC.

Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com.

Share article on social media or email:

Industry: Healthcare

Interim HealthCare Inc. Ranks on Staffing Industry Analysts 2019 Annual Lists

Leave a comment


News Image

“It’s an honor to be recognized among so many impressive companies that share our commitment to delivering a world-class experience for both our employees and our clients,” said Jennifer Sheets, Interim HealthCare Inc. CEO and President.


SUNRISE, Fla. (PRWEB)

Interim HealthCare Inc., a leading national franchisor of home care, hospice and healthcare staffing, was ranked No. 45 on Staffing Industry Analysts (SIA) 2019 Largest Healthcare Staffing Firms list and No. 10 on SIA’s Largest Per Diem Nurse Staffing Firms list.

For this year’s report, SIA estimates that 49 firms generated staffing revenue of $50 million or more in 2018, and added together, generated $12.7 billion in staffing revenue, which accounts for 75% of the market. Travel nurses and per diem nurses made up the majority of the market size estimates, $5.4 billion and $3.6 billion respectively.

“It’s an honor to be recognized among so many impressive companies that share our commitment to delivering a world-class experience for both our employees and our clients,” said Jennifer Sheets, Interim HealthCare Inc. CEO and President. “This ranking is a testament to the compassion, expertise and integrity our franchisees and healthcare professionals bring to every client interaction, and we’re proud to build upon our over 50-year history of providing the highest quality care in the communities we serve.”

SIA ranked companies by revenue, according to industry custom. SIA corporate members can download the full report online here. For more details about Interim HealthCare’s staffing services, visit https://www.interimhealthcare.com/services/staffing.

About Interim HealthCare Inc.

Interim HealthCare Inc., founded in 1966, is a leading national franchisor of home care, hospice and healthcare staffing. It is part of Caring Brands International, which also includes UK-based Bluebird Care and Australia-based Just Better Care, both well-known franchise brands in their countries. With more than 530 franchise locations in seven countries, Caring Brands International is a global health care leader.

Interim HealthCare in the United States is unique in combining the commitment of local ownership with the support of a national organization that develops innovative programs and quality standards that improve the delivery of service. Franchisees employ nurses, therapists, aides, companions and other healthcare professionals who provide 25 million hours of home care service to 190,000 people each year, meeting a variety of home health, senior care, hospice, palliative care, pediatric care and healthcare staffing needs. For more information or to locate an Interim HealthCare office, visit http://www.interimhealthcare.com.

Share article on social media or email:

Health

KinderLab Introduces KIBO Robotics Course for the Youngest Homeschoolers

Leave a comment


News Image


WALTHAM, Mass. (PRWEB)

KinderLab Robotics today announced a new three-month KIBO Home Robotics Course that enables home educators and caregivers to introduce coding and robotics to their young learners without computers or screen time. The course provides a step-by-step curriculum to easily teach coding, robotics, and STEAM concepts, and includes use of a KIBO 18 Robot Kit to support the curriculum. This unique rental program makes creative, cross-curricular STEM/STEAM learning affordable and easy to implement for homeschool educators.

KIBO is a hands-on, playful robot that offers young children a fun way to learn coding and building along with storytelling and imaginative play. KIBO is entirely unplugged and screen-free: no smartphone, tablet, PC, or network connection is needed. Children use wooden blocks to program their own robot, then build onto the robot with art and craft materials to create a character to act out their story or lesson.

KIBO is the result of extensive research by KinderLab co-founder Dr. Marina Bers, Chair of the Eliot-Pearson School of Child Study and Human Development at Tufts University. Dr. Bers has shown that children engage with powerful ideas in computational thinking, the engineering design process, and social-emotional learning (SEL) by imagining and creating with technological tools. Dr. Bers’ research demonstrates that when children create and express themselves with age appropriate technologies, they develop not just technical skills but also confidence, perseverance, and creativity.

Jason Innes, the manager of training and curriculum development at KinderLab Robotics, Inc., said, “As the first educational robotics company to offer a program specifically designed for home educators, our goal is for KIBO to help level the playing field and offer homeschoolers the same opportunities their peers have in public schools. Adding coding, robotics, and STEAM to a homeschool curriculum can feel difficult—and expensive. We’re offering the KIBO Home Robotics Course as a rental program to create an affordable, step-by-step, supportive way to include KIBO in home learning environments.”

The KIBO Home Robotics Course integrates arts and crafts into STEAM learning. As children develop their computational thinking and coding skills with KIBO, they can use their robot to tell stories, choreograph dances, create a vehicle to explore a cardboard town, create programs that model the behavior of animals in their habitats, and more. Coding becomes a new literacy that children can use to explore their other subjects more deeply.

With the three-month KIBO Home Robotics Course, home educators have full support from KinderLab Robotics as they integrate coding and robotics into their homeschool curriculum. In addition to the complete, research-backed Creating with KIBO curriculum, the program includes fun Activity Cards, helpful workbooks, and a clear lesson sequence. Course participants also receive weekly emails with specific advice, examples, and suggestions keyed to their progress through the course.

The KIBO Home Robotics Course is available now at KinderLabRobotics.com/at-home. The program fee of $169 includes the three-month KIBO rental, complete curriculum, and two-way shipping anywhere in the continental United States (additional shipping charges apply for US locations outside the continental US).

When participants complete the three-month course, they can use the pre-paid shipping label to return the course materials to KinderLab. Families who would like to continue using KIBO to support STEAM learning in the home can instead choose to purchase their KIBO Robot Kit at a significant discount. After purchasing, they can extend their KIBO experience with a range of fun add-ons and extension sets.

About KIBO – The Playful STEAM Robot

KIBO is a robot kit that allows children aged 4–7 to build, program, decorate, and bring their own robot to life without requiring any screen time on a smartphone, tablet, or computer. It is an open platform on which students can envision and create their own robot. With art and engineering, students transform KIBO into imagined animals, vehicles, storybook characters, and more. Students plan a coding sequence using wooden programming blocks, then scan their sequence with the built-in barcode scanner, press its button—and the robot comes alive.

When children build, code, and decorate their own robot, they perceive it as play, but they are learning invaluable STEAM skills. Not only are these hands-on experiences inherently rewarding, but they help children understand the technology in their world and can even improve their future job prospects.

About KinderLab Robotics

KinderLab Robotics is the creator of the award-winning KIBO, a playful educational STEAM robot kit based on 20 years of child development research with thousands of children, teachers, and parents. Developed specifically for teachers by Dr. Marina Umaschi Bers at Tufts University, KIBO is currently used in 59 countries and has proven efficacy in helping kids learn STEAM—and getting them excited about it! KinderLab offers a complete suite of teaching materials that help integrate STEAM elements into a wide range of curricula, including art, cultural studies, and reading literacy.

For more information, please visit KinderLabRobotics.com.

Press Contact

Chris Piehler

PR with Panache!

chris@prwithpanache.com

Share article on social media or email:

Lifestyle: Self Help

REVIV, The World’s Leading Lifestyle and Wellness Company, Announces The North Face Founder, Hap Klopp, as New Board Member

Leave a comment


https://www.prweb.com/

Hap Klopp Joins REVIV Board

“Hap’s coming on board represents a seismic jump for REVIV,” said Sarah Lomas, President, REVIV. “His widespread knowledge and groundbreaking methods place REVIV at the perfect juncture to move from IV therapy to overall wellness based on disruptive and groundbreaking genetic analysis.”


NEW YORK (PRWEB)

REVIV, a leading global brand in preventative health, offering IV therapies and cutting edge lifestyle genetics services to deliver a unique approach to holistic wellness, has announced the newest member to its advisory board, effective September 1: Kenneth “Hap” Klopp, the founder and 20-year-CEO of The North Face, one of the leading international sports apparel companies.

Klopp will serve REVIV as Non-Executive Director. He runs a private consulting company, HK Consulting, which specializes in strategy, global business, marketing and sales for sports, apparel and financial services companies. He is a Board member of numerous entrepreneurial ventures and the author of Conquering The North Face–an adventure in Leadership, and ALMOST–12 electric months chasing a Silicon Valley Dream.

He is also a lecturer and motivational speaker specializing in strategy, brand building, M&A and financing.

“Hap’s coming on board represents a seismic jump for REVIV,” said Sarah Lomas, President, REVIV. “His widespread knowledge and groundbreaking methods place REVIV at the perfect juncture to move from IV therapy to overall wellness based on disruptive and groundbreaking genetic analysis.”

“REVIV is a major disruptor in the DNA testing industry,” said Klopp. “Its depth and excellence will make it the new standard that delivers the triple bottom line: profits, environmental health and societal improvement.”

In addition, REVIV will undertake its Series Round A funding in a few weeks and Klopp will be contributing his extensive entrepreneurial experience to facilitate the financing.

REVIV Genetics is the most accurate DNA testing available today at 99.97% accuracy. While currently the only company to provide personal follow-up consultation, REVIV is branching out to offer DNA testing and fully personalized IV therapies designed to maximize individual overall health.

About REVIV

REVIV now operates across six continents, with clinics located in over 35 countries, firmly establishing itself as the global market leader in IV therapy-led preventative health solutions.

In September 2019, the company introduced REVIV Genetics, the new disruptive lifestyle genetics service to perfectly complement its overall wellness and preventative health strategy.

REVIV Genetics has the broadest offering of lifestyle genetic tests and the most comprehensive analysis available on the market today, providing bespoke health and wellness therapy at its highest accuracy via a very safe and secure doctor-led service. Results come with information on how to prevent or improve health outcomes and REVIV’s experienced medical team provide tools to apply the advice to daily life and lifestyle. These include food and medication lists and high-level preventative tips.

Share article on social media or email:

health and fitness

Surfing Madonna Beach Run a Resounding Success with Over 3,400 Participants from 17 States and Six Countries

Leave a comment


high angle view of runners on a beach

Over 3,400 runners from 17 different states and six different countries came together to participate in the Surfing Madonna Beach Run, sponsored in part by Herman Cook Volkswagen of Encinitas.

Over 3,400 runners from 17 different states and six different countries came together to participate in the Surfing Madonna Beach Run, which was sponsored in part by Herman Cook Volkswagen of Encinitas.


ENCINITAS, Calif. (PRWEB)

The Surfing Madonna Beach Run, which took place on Saturday, October 26, 2019, in Encinitas, California, was a resounding success for all involved, allowing the annual event to keep its title as the “Largest Race on Sand” from the Guinness Book of World Records.

Over 3,400 runners from 17 different states and six different countries came together to participate in the race, which was sponsored in part by Herman Cook Volkswagen of Encinitas.

Among those runners were multiple participants from countries such as Mexico, Canada and England. The runners were assisted throughout the day by a dedicated and hard-working group of 364 volunteers.

The runners enjoyed a scenic beach run of either 5 kilometers, 10 kilometers or 12 kilometers, starting at Moonlight Beach in Encinitas and then heading up the coast to Beacons Beach and Ponto Beach before heading south to Swami’s Beach.

Before the race started, participants were treated to two dances performed by the University of California San Diego dance team, which is ranked 10th in the nation.

After the race, participants were gifted a carved wood medal, a race shirt, a race mug and treats galore. They were also treated to a live performance by local Encinitas musicians, Bucket Ruckus.

Proceeds from the event are being used to support the Surfing Madonna Beach Run and its Oceans Project efforts to protect the coastline.

Those efforts are one of the main reasons Herman Cook Volkswagen chooses to sponsor the race, as everyone at the dealership is committed to supporting the local beach community and the efforts taking place to preserve the beauty and health of those beaches. Herman Cook VW is grateful to be a sponsor of the event and is proud of all the runners and spectators who came out to participate.

More information on Herman Cook Volkswagen can be found by visiting the dealership’s website or by calling its friendly and knowledgeable staff at 855-637-8636. Herman Cook Volkswagen is located at 1435 Encinitas Boulevard in Encinitas.

Share article on social media or email:

Industry: Healthcare

Dr. Neda Shamie Partners with the Exclusive Haute Beauty Network

Leave a comment


Neda Shamie, MD is a renowned LASIK, cataract, and corneal surgeon and partner of the Maloney-Shamie Vision Institute in Los Angeles, CA.


LOS ANGELES (PRWEB)

The Haute Beauty Network, well known for its exclusive and luxurious lifestyle publication Haute Living is privileged to present Dr. Neda Shamie as a visual expert and our newest addition to the Haute Beauty members-only network.

Haute Beauty offers a prominent collective of leading doctors. The invitation-only exclusive publication maintains elite as ever, with only two doctors in every market. This partnership allows Haute Beauty to connect its affluent readers with industry-leading aesthetic surgeons located in their area.

Neda Shamie, MD is a renowned LASIK, cataract, and corneal surgeon and partner of the Maloney-Shamie Vision Institute in Los Angeles. She previously was the Medical Director of the Doheny Eye Institute and is a Clinical Professor of Ophthalmology at the USC Keck School of Medicine.

ABOUT DR. NEDA SHAMIE

Dr. Shamie graduated Summa Cum Laude with high honors from UCLA and obtained her medical degree from UCSF School of Medicine. She completed her residency and fellowship training in corneal and laser refractive surgery at UC Irvine where she also served as Director of the Corneal Service. Soon thereafter she joined the Devers Eye Institute in Portland, Oregon, where together with Dr. Mark Terry, they spearheaded many projects and advances in the field of lamellar corneal transplantation with emphasis on endothelial keratoplasty (DSEK and DMEK).

Dr. Shamie was the first surgeon in the Northwest to offer both artificial corneal transplantation and DMEK surgery to her patients. Recognized as an expert in complex vision correction surgery, Dr. Shamie has coauthored over 50 publications on the topics of cataract surgery and corneal transplantation, written 8 chapters for surgical textbooks and has led international lectures, courses, and seminars teaching colleagues about the advances in vision correction surgery. In 2017, the American Academy of Ophthalmology awarded her the Senior Achievement Award for contributions to the education of other eye surgeons. She has trained and instructed over 500 surgeons and has personally performed over 6,500 vision correction surgeries.

She is an active member of numerous ophthalmic societies, has served on the Cornea Clinical Committee of the American Society of Cataract and Refractive Surgery, was the President of the Los Angeles Society of Ophthalmology and has been voted by peers to be among America’s Top Doctors.

Dr. Neda Shamie specializes in advanced vision correction surgery including LASIK, PRK, ICLs, refractive lens exchange, and advanced lens laser cataract surgery. She also is an expert in complex corneal transplant surgeries including DMEK, DSEK, DALK, and PKP as well as the breakthrough, non-invasive keratoconus treatment, Collagen Cross-Linking.

Visit Dr. Shamie’s profile on Haute Beauty: https://hauteliving.com/hautebeauty/member/dr-neda-shamie/

Share article on social media or email:

Health: Mental Health

Partnership for Children’s Mental Health, a Center Focused on Improving the Youth Mental Health System in Colorado

Leave a comment



COLORADO SPRINGS, Colo. (PRWEB)

The Quad Innovation Partnership (QIP), the only higher education partnership of its kind in the United States, is pleased to announce new work with Partners for Children’s Mental Health (PCMH), a center supported by Children’s Hospital Colorado and the University of Colorado Department of Psychiatry.

PCMH operates as across-system resource, training, and implementation hub in order to ultimately increase capacity, access, and quality of youth mental health services in Colorado. It works with partners across the state to identify, scale, and sustain best practices to help connect youth and families to effective mental health treatment and, ultimately, save lives.

One of PCMH’s key action items is school-based mental health care and suicide prevention. Students from QIP will conduct and deliver interdisciplinary research to assess best practice suicide prevention programs that address key risk factors among elementary and middle school students in Colorado. PCMH currently offers support to high schools; the project will help PCMH expand support to elementary and middle school students statewide.

“The Quad works on many important initiatives that impact our communities and this initiative with Partners for Children’s Mental Health is one of the most critical items our organization has been a part of,” said Jake Eichengreen, Executive Director of the Quad Innovation Partnership. “As noted by PCMH, suicide is the #1 cause of death among Colorado youth ages 10-24. This is a massive problem and we have assembled a dedicated team to produce outcomes for PCMH that address real need and will strengthen their essential work.”

QIP is comprised of students, staff and faculty from Colorado College, Pikes Peak Community College, University of Colorado Colorado Springs and the US Air Force Academy. This diverse group delivers professional-grade recommendations, tactics and solutions for a varied array of clients, covering a wide range of initiatives and issues that impact the lives of people in southern Colorado and the nation.

“The Quad’s recommendations will be critical to our efforts to provide a scalable, low-cost suicide prevention package to schools across Colorado,” said Shannon Van Deman, Executive Director of Partners for Children’s Mental Health and Vice President of the Pediatric Mental Health Institute at Children’s Hospital Colorado. “The Quad is recognized as a leader tackling some of the biggest challenges facing our state. We’re excited to partner with them to create real impact for youth and families.”

The project was made possible through the generosity of Mark and Shannon Breuer and their family, who are dedicated to supporting the most effective initiatives in expanding behavioral health access, reducing youth suicide, and positively impacting our community’s children and families. 

About the Quad Innovation Partnership: A collaborative initiative of Colorado College, Pikes Peak Community College, University of Colorado at Colorado Springs and the United States Air Force Academy[1], the Quad deepens the ability of graduates to innovate within professional settings in the Pikes Peak Region. As the only initiative combining the capacities, students and faculty of a private liberal arts college, a regional community college, a state research university and a US service academy in the United States, the Quad’s value is built on the diversity of institutions it represents. All projects the Quad facilitates leverage the combined capacities of these four institutions in order to work together to discover, validate and initiate solutions for public, private and philanthropic clients

[1] Insofaras authorized by Federal law. The Quad is not an organization of the Federal government and USAFA offers no underwriting or endorsement of the activities.

Share article on social media or email:

Health

Proscia® Granted U.S. Patent for AI-Powered Dermatopathology

Leave a comment



PHILADELPHIA (PRWEB)

Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,460,150 by the United States Patent and Trademark Office (USPTO). The patent discloses techniques related to using deep learning to read and process digital images of skin biopsies and output findings for use in diagnosis, decision support, and triaging.

The standard of care for diagnosing tissue biopsies depends on a pathologist’s interpretation of patterns as viewed through a microscope. This 150-year-old manual and subjective practice cannot keep pace with the growing demand for diagnostic services, especially as the population of pathologists continues to decline. Dermatopathology exemplifies this trend. In the U.S., there are only 1,000 board-certified dermatopathologists available to read the 25 million skin biopsies taken annually; meanwhile, the number of new cases of melanoma diagnosed is estimated to increase by 7.7% this year alone.

This mounting cancer burden, in part, has given rise to digital pathology whereby specialized scanners transform tissue samples on glass slides into whole slide images. Whole slide images can be analyzed by Proscia’s Concentriq® software when coupled with its artificial intelligence applications to drive efficiency, quality, and confidence gains.

U.S. Patent No. 10,460,150 relates to techniques for using artificial intelligence to classify skin specimens into at least one of three diagnostic categories: basal cell carcinoma, dermal nevus, or seborrheic keratosis. It describes techniques that involve obtaining a computer-readable image of a human cutaneous tissue sample, processing the image using deep learning to output a diagnosis including at least one of the three categories, and outputting that diagnosis into an electronic medical records (EMR) system or displaying it to a human pathologist for confirmation.

The diagnostic categories considered in the patent account for the majority of dermatopathology cases. Systems as disclosed by the patent could drive significant workflow efficiencies by optimizing how dermatopathology cases are distributed across the laboratory to make the most of precious pathology resources. With appropriate development, validation, and regulatory approval, a covered system could also increase diagnostic accuracy to improve patient outcomes.

In June 2019, Proscia released DermAI™, an AI application on its Concentriq platform*, which utilizes techniques covered by this patent to deliver capabilities including intelligent workload balancing and case prioritization as well as automated QA and 100% AI re-review. This patent also supports Proscia’s product roadmap for enhancing DermAI with advanced capabilities to aid pathologists in making diagnostic decisions.

This patent is the second granted to Proscia this year. In September, Proscia was granted U.S. Patent No. 10,346,980, which relates to techniques for processing and analyzing medical images critical to the advancement of digital pathology.

About Proscia

Proscia is a software company that is changing the way the world practices pathology to transform cancer research and diagnosis. With the company’s Concentriq digital pathology platform and pipeline of AI algorithms, laboratories are leveraging new kinds of data to improve patient outcomes and accelerate discoveries. Proscia’s team of technologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision care. For more information, visit proscia.com.

*Proscia’s products are not approved for primary diagnosis.

Share article on social media or email: